PAG
ANIX icon

Private Advisor Group’s Anixa Biosciences ANIX Stock Holding History

Private Advisor Group’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.4K Hold
10,221
– – ﹤0.01% 2613
2025
Q4 		$31.9K Sell
10,221
-3,525
-26% -$14.4K ﹤0.01% 2543
2025
Q3 		$45.4K Buy
13,746
+2,132
+18% +$6.75K ﹤0.01% 2456
2025
Q2 		$38.3K Sell
11,614
-750
-6% -$2.14K ﹤0.01% 2363
2025
Q1 		$35.4K Buy
+12,364
New +$35.4K ﹤0.01% 2249
2020
Q3 		– Sell
-320
Closed -$1K – 1649
2020
Q2 		$1K Buy
+320
New +$664 ﹤0.01% 3660

Other funds holding ANIX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Private Advisor Group's ANIX Position: Q1 2026 in Review

Private Advisor Group held its Anixa Biosciences (ANIX) position steady in Q1 2026 at 10,221 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2613.

Private Advisor Group first reported a position in ANIX in Q2 2020 and has held it in 6 quarters since. The position peaked at $45.4K in Q3 2025. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Private Advisor Group held 10,221 shares of Anixa Biosciences worth $26.4K as of Q1 2026.
  • Private Advisor Group left its Anixa Biosciences share count unchanged in Q1 2026.
  • Anixa Biosciences made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #2613 holding.
  • Private Advisor Group first reported a position in Anixa Biosciences in Q2 2020 and has held it in 6 quarters since.
  • Private Advisor Group's Anixa Biosciences position peaked at $45.4K in Q3 2025.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.